Breaking News Instant updates and real-time market news.

EBAY

eBay

$39.03

-0.87 (-2.18%)

, LLNW

Limelight Networks

$2.77

0.18 (6.95%)

18:52
07/17/19
07/17
18:52
07/17/19
18:52

Fly Intel: After Hours Movers

UP AFTER EARNINGS: eBay (EBAY) up 6.1%. DOWN AFTER EARNINGS: Limelight Networks (LLNW) down 19.6%... Netflix (NFLX) down 12.0%... United Rentals (URI) down 5.8%... Crown Holdings (CCK) down 4.0%... Alcoa (AA) down 2.7%... Kinder Morgan (KMI) down 2.0%... Texas Capital Bancshares (TCBI) down 2.0%... IBM (IBM) down 1.6%. ALSO LOWER: Amarin (AMRN) down 9.7% after equity offering... Roku (ROKU) down 2.9% in sympathy with Netflix... New York Mortgage Trust (NYMT) down 2.1% after equity offering. Movers as of 18:30ET.

EBAY

eBay

$39.03

-0.87 (-2.18%)

LLNW

Limelight Networks

$2.77

0.18 (6.95%)

NFLX

Netflix

$362.50

-3.22 (-0.88%)

URI

United Rentals

$131.55

-6.05 (-4.40%)

CCK

Crown Holdings

$59.38

-0.88 (-1.46%)

AA

Alcoa

$23.15

-0.18 (-0.77%)

KMI

Kinder Morgan

$20.60

-0.3 (-1.44%)

TCBI

Texas Capital

$58.67

-0.76 (-1.28%)

IBM

IBM

$143.07

-0.47 (-0.33%)

AMRN

Amarin

$21.06

-0.68 (-3.13%)

ROKU

Roku

$109.33

-2.575 (-2.30%)

NYMT

New York Mortgage

$6.25

-0.01 (-0.16%)

  • 17

    Jul

  • 17

    Jul

  • 17

    Jul

  • 17

    Jul

  • 17

    Jul

  • 17

    Jul

  • 17

    Jul

  • 17

    Jul

  • 18

    Jul

  • 18

    Jul

  • 18

    Jul

  • 07

    Aug

  • 26

    Aug

  • 23

    Sep

  • 28

    Sep

  • 18

    Jul

  • 19

    Jul

EBAY eBay
$39.03

-0.87 (-2.18%)

07/16/19
BARD
07/16/19
NO CHANGE
Target $44
BARD
Outperform
eBay volume survey shows softness in June, says Baird
Baird analyst Colin Sebastian said his proprietary survey of eBay volume suggests year-over-year volume declines persisted into June, partially reflecting tougher comps from elevated promotional activity last year. The analyst said trends may show early improvement in Q3 as the survey showed signs of improvement in July. Sebastian maintained his Outperform rating and $44 price target on eBay shares.
06/17/19
BARD
06/17/19
NO CHANGE
Target $44
BARD
Outperform
eBay traffic survey reflects continued softness, says Baird
Baird analyst Colin Sebastian said his proprietary eBay tracker showed continued softness for May. The data suggests growth headwinds and he believes the new taxes on small business sellers will continue to have an impact on eBay's merchant base, further driving ongoing softness. Sebastian maintained his Outperform rating and $44 price target on eBay shares.
06/14/19
CHLM
06/14/19
NO CHANGE
CHLM
Buy
Facebook cryptocurrency would be 'positive' for PayPal, says Craig-Hallum
Craig-Hallum analyst Brad Berning tells investors in a research note that a Facebook (FB) cryptocurrency would be a "positive" for Buy-rated PayPal (PYPL), as it could drive higher adoption of Braintree merchant acceptance and the Facebook marketplace, which according to CFO John Rainey, could dwarf eBay (EBAY).
07/16/19
STFL
07/16/19
NO CHANGE
Target $41
STFL
Hold
eBay likely relatively range bound in intermediate term, says Stifel
Stifel analyst Scott Devitt offered his preview of eBay's upcoming Q2 report on July 17, noting that his revenue forecast is modestly below consensus while his non-GAAP EPS estimate is in-line with the consensus view. While he believes Promoted Listings will continue to be a bright spot, Devitt expects eBay share to "relatively range bound in the intermediate term" as he thinks favorable developments related to its strategic review are needed before shares will move meaningfully higher. Devitt keeps a Hold rating and $41 price target on eBay shares.
LLNW Limelight Networks
$2.77

0.18 (6.95%)

07/16/19
COWN
07/16/19
NO CHANGE
Target $4.5
COWN
Outperform
Limelight Networks a "show me story" but meaningfully undervalued, says Cowen
Cowen analyst Jonathan Charbonneau previewed Q2 earnings for Limelight Networks and called it a "show me story" and believes it will take multiple quarters of consistent results for the stock to work, especially given the back-end loaded nature of its guidance. The analyst said despite it being a second half story, he believes it is meaningfully undervalued and he remains constructive on the name. Charbonneau reiterated his Outperform rating and $4.50 price target on Limelight Networks shares.
01/29/19
01/29/19
UPGRADE

Market Perform
Limelight Networks upgraded to Market Perform at Raymond James
As previously reported, Raymond James upgraded Limelight Networks to Market Perform from Underperform. Analyst Michael Turits said his thesis on competition is "played out" following several recent contract losses, and thinks competition has likely stabilized. Further, Turits sees new opportunities around Edge Computing and security emerging for CDNs.
07/02/19
DADA
07/02/19
INITIATION
Target $2.7
DADA
Neutral
Limelight Networks assumed with a Neutral at DA Davidson
DA Davidson analyst Rishi Jaluria assumed coverage of Limelight Networks with a Neutral rating and $2.70 price target. In a research note to investors, Jaluria says that while management, led by CEO Bob Lento and CFO Sajid Malhotra, has done an "impressive" job turning around the company, after the turnaround yielded four consecutive quarters of double-digit revenue growth, growth has turned negative and pressured margins at the same time. As a result, Jaluria says he remains in "wait-and-see mode" for now.
07/02/19
RILY
07/02/19
NO CHANGE
Target $4.9
RILY
Buy
Limelight Networks removed from Alpha Generator List at B. Riley FBR
B. Riley FBR analyst Lee Krowl removed Limelight Networks from his firm's Alpha Generator List citing the suggested time frame for its inclusion on the list. The analyst keeps a Buy rating on the shares with a $4.90 price target.
NFLX Netflix
$362.50

-3.22 (-0.88%)

07/17/19
LYNX
07/17/19
NO CHANGE
LYNX
Key for Netflix earnings is International subscriber guidance, says Lynx
Lynx Equity Strategies analysts KC Rajkumar and Jahanara Nissar said ahead of Netflix's Q2 earnings that the key for the company's earnings report is the Q3 International subscriber guidance, noting that investors are looking for 5.5M or better for the stock to go higher, and "anything less may result in a flattish stock performance over the next week." The analysts suggest to "wait this one out."
07/16/19
MSCO
07/16/19
NO CHANGE
Target $450
MSCO
Overweight
Netflix price increases support healthy ARPU growth, says Morgan Stanley
In a preview of the upcoming earnings report from Netflix, Morgan Stanley analyst Benjamin Swinburne said he expects the company to again deliver record net additions in FY19 and near double digit ARPU growth supported by its recent price increases. He remains in-line with guidance for 300,000 U.S. paid net adds and 4.7M international net adds in Q2 and raised his Q3 revenue and earnings estimates for more international price increases than he'd previously expected. Swinburne keeps an Overweight rating and $450 price target on Netflix shares.
07/15/19
KEYB
07/15/19
NO CHANGE
KEYB
Sector Weight
KeyBanc expects Netflix to report in-line results, guidance
Ahead of Netflix's quarterly results, KeyBanc analyst Andy Hargreaves expects modest upside to Q2 guidance and Q3 subscriber guidance that is largely in line with current sell-side expectations. While the analyst sees the potential for some upside to this expectation, he maintains the magnitude of upside is likely to be limited, which is likely to prevent material near-term stock appreciation. Hargreaves has a Sector Weight rating on the shares.
07/12/19
FBCO
07/12/19
NO CHANGE
Target $450
FBCO
Outperform
Netflix app download trends weakened 'dramatically' in Q2, say Credit Suisse
Credit Suisse analyst Douglas Mitchelson tells investors in a research note that Netflix app download trends weakened dramatically in the second quarter, with global downloads up 8% year-over-year vs. an increase of 24% y/y in the first quarter, driven by price increases and was anticipated in guidance. Mitchelson, who maintains an Outperform rating, $450 price target and second quarter estimates, notes downside risk and little upside potential for Q2 international net adds.
URI United Rentals
$131.55

-6.05 (-4.40%)

06/28/19
UBSW
06/28/19
NO CHANGE
Target $170
UBSW
Buy
United Rentals shares undervalued barring severe recession, says UBS
Barring a severe recession, shares of United Rentals are undervalued as the company is significantly different now versus prior downturns, UBS analyst Steven Fisher tells investors in a research note. The analyst estimates that a "relatively mild" recession, akin to 2001/2002, could result in a 5%-10% decline in EBITDA, versus the ~20% decline in EBITDA United Rentals experienced in 2002. He believes such a decline is largely priced into United Rentals shares at current levels. The analyst keeps a Buy rating on United Rentals with a $170 price target.
12/14/18
LEHM
12/14/18
INITIATION
Target $130
LEHM
Equal Weight
United Rentals reinstated with an Equal Weight at Barclays
Barclays analyst Adam Seiden reinstated coverage of United Rentals with an Equal Weight rating and $130 price target. The analyst sees "slow, steady" low-to-mid single-digit growth for the rental industry in 2019, United Rentals included. He sees an even risk/reward at current share levels.
02/19/19
STPT
02/19/19
DOWNGRADE
STPT
Hold
United Rentals downgraded to Hold from Buy at Standpoint Research
04/01/19
OTRG
04/01/19
DOWNGRADE
OTRG
Mixed
United Rentals downgraded to Mixed from Positive at OTR Global
OTR Global downgraded United Rentals to Mixed from Positive following checks that indicate flattening utilization and growth.
CCK Crown Holdings
$59.38

-0.88 (-1.46%)

05/31/19
BARD
05/31/19
NO CHANGE
Target $65
BARD
Outperform
Crown Holdings weakness a buying opportunity, says Baird
Baird analyst Ghansham Panjabi believes the recent selloff in Crown Holdings is myopic and that the bull thesis remains intact. He believes the shares sold off in part due to profit-taking after a healthy year-to-date performance as well as concerns over Signode-driven macroeconomic exposure and leverage. The analyst believes the pullback has created an opportunistic entry point. Panjabi reiterated his Outperform rating and $65 price target on Crown Holdings shares.
04/22/19
DBAB
04/22/19
NO CHANGE
Target $65
DBAB
Buy
Crown Holdings price target raised to $65 from $60 at Deutsche Bank
Deutsche Bank analyst Debbie Jones raised her price target for Crown Holdings to $65 from $60 saying the company's Q1 results were a "good start to the year with robust beverage can demand." The analyst remains positive on the shares despite the Q2 outlook coming in a "tough light." She keeps a Buy rating on Crown Holdings.
02/19/19
RBCM
02/19/19
NO CHANGE
Target $64
RBCM
Outperform
Crown Holdings price target raised to $64 from $58 at RBC Capital
RBC Capital analyst Arun Viswanathan raised his price target on Crown Holdings to $64 and kept his Outperform rating, noting that while the company is facing FX headwinds in the first half of 2019, its global beverage can business should remain robust and near the 4% growth level seen in 2018. The analyst adds that the company's recently acquired Signode business should show stable earnings with limited cyclicality, with further benefits coming from Crown Holdings' deleveraging efforts.
06/19/19
DBAB
06/19/19
NO CHANGE
DBAB
Buy
Constellium a winner of upcoming can sheet shortage, says Deutsche Bank
The stable demand of aluminum beverage can sheet along with little-to-no investment by production companies has tightened markets, Deutsche Bank analyst Jeremy Kliewer tells investors in a research note. The analyst believes that as legacy can sheet contracts roll-off, new contracts are likely to reflect the tightened supply dynamics through higher pricing. With roughly 50% of Constellium's (CSTM) production/shipment volumes exposed to aluminum can sheet, Kliewer sees the company as the largest beneficiary of upcoming can sheet prices increasing. He raised his 2020-2021 EBITDA estimates by 5% to reflect the company's packaging sheet margins widening and recommends buying the shares. The analyst reiterates a Buy ratings on Constellium and Alcoa (AA), as well as packaging companies Ball Corp. (BLL), Crown Holdings (CCK) and Ardagh Group (ARD).
AA Alcoa
$23.15

-0.18 (-0.77%)

07/11/19
07/11/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Parker-Hannifin (PH) downgraded to Market Perform from Outperform at Wells Fargo with analyst Andrew Casey saying future potential appears to be increasingly complicated by ongoing end market growth deceleration in the U.S. 2. Allstate (ALL) downgraded to Underperform from Neutral at Credit Suisse with analyst Michael Zaremski calling it the insurer most levered to homeowners' insurance at a time when record levels of precipitation in the U.S. raises the probability of worse than expected "non-catastrophe" claims volumes in the homeowners' line of business. 3. Alcoa (AA) downgraded to Hold from Buy at Deutsche Bank with analyst Chris Terry saying he previously thought Alcoa's legacy liabilities from pension and debt would reduce, the aluminum chain pricing will improve, and that its free cash flow would increase. However, he no longer sees this playing out in the near term. 4. Werner (WERN) downgraded to Underperform from Neutral at Credit Suisse with analyst Allison Landry saying that with a weakening demand backdrop, contract TL rates that are turning negative, and anecdotal evidence that suggests capacity remains relatively loose, she sees fairly meaningful risk to the second half of 2019 and 2020 EPS for the asset based truckers. 5. Hamilton Lane (HLNE) downgraded to Underperform from Market Perform at Keefe Bruyette with analyst Robert Lee citing valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/11/19
DBAB
07/11/19
DOWNGRADE
Target $23
DBAB
Hold
Deutsche Bank downgrades Alcoa to Hold, cuts price target to $23
Deutsche Bank analyst Chris Terry last night downgraded Alcoa to Hold from Buy and lowered his price target for the shares to $23 from $35. The analyst previously thought Alcoa's legacy liabilities from pension and debt would reduce, the aluminum chain pricing will improve, and that its free cash flow would increase. However, he no longer sees this playing out in the near term.
07/10/19
DBAB
07/10/19
DOWNGRADE
DBAB
Hold
Alcoa downgraded to Hold from Buy at Deutsche Bank
07/09/19
07/09/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. 3M (MMM) downgraded to Sector Perform from Outperform at RBC Capital with analyst Deane Dray expecting the overhang on the shares from macro pressures and litigation to persist. 2. Marriott (MAR) and Hilton (HLT) downgraded to Neutral from Overweight at JPMorgan, while Ryman Hospitality (RHP) and CorePoint Lodging (CPLG) were downgraded to Underweight from Neutral. 3. Alcoa (AA) downgraded to Neutral from Outperform at Macquarie. 4. First Business Financial (FBIZ) downgraded to Neutral from Buy at DA Davidson with analyst Kevin Reevey saying the rating change is driven purely by the recent 33% advance in the stock price from its 52-week lows to within 6% of its 52-week highs. 5. Myriad Genetics (MYGN) downgraded to Market Perform from Outperform at Cowen with analyst Doug Schenkel citing a combination of lower overall conviction in Myriad and a less attractive relative valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
KMI Kinder Morgan
$20.60

-0.3 (-1.44%)

06/26/19
RAJA
06/26/19
DOWNGRADE
RAJA
Market Perform
Kinder Morgan downgraded to Market Perform from Outperform at Raymond James
As previously reported, Raymond James downgraded Kinder Morgan to Market Perform from Outperform. Analyst Justin Jenkins said shares are up approximately 35% year-to-date and trade at an above-peer multiple despite a mixed outlook for the asset portfolio.
06/17/19
STFL
06/17/19
DOWNGRADE
STFL
Hold
Kinder Morgan downgraded to Hold from Buy at Stifel
Stifel analyst Selman Akyol downgraded Kinder Morgan to Hold from Buy with an unchanged price target of $22. The analyst continues to view Kinder favorably given its recent reduction to "more moderate" leverage, high coverage, and dividend growth, but he believes the current valuation reflects this.
06/26/19
06/26/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. State Street (STT) downgraded to Neutral from Buy at UBS with analyst Brennan Hawken saying he has "very little confidence" in when the company will be able to get past the headwinds it is facing. 2. Allergan (AGN) downgraded to Neutral from Buy at Mizuho with analyst Irina Koffler saying she views the AbbVie (ABBV) deal as "a hard-fought and timely exit" for shareholders, citing her concerns about the weakness in Allergan's aesthetics portfolio and the company's growth challenges. 3. Kinder Morgan (KMI) downgraded to Market Perform from Outperform at Raymond James with analyst Justin Jenkins saying shares are up approximately 35% year-to-date and trade at an above-peer multiple despite a mixed outlook for the asset portfolio. 4. Papa John's (PZZA) downgraded to Neutral from Buy at Kalinowski. 5. Illinois Tool Works (ITW) downgraded to Sell from Neutral at Northcoast with the firm's analyst citing concentrated Automotive exposure. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/26/19
RAJA
06/26/19
DOWNGRADE
RAJA
Market Perform
Kinder Morgan downgraded to Market Perform from Outperform at Raymond James
TCBI Texas Capital
$58.67

-0.76 (-1.28%)

05/28/19
BERN
05/28/19
UPGRADE
BERN
Outperform
Texas Capital upgraded to Outperform from Market Perform at Bernstein
06/07/19
PIPR
06/07/19
DOWNGRADE
Target $64.5
PIPR
Neutral
Texas Capital downgraded to Neutral from Overweight at Piper Jaffray
Piper Jaffray analyst Brett Rabatin downgraded Texas Capital Bancshares to Neutral from Overweight and lowered his price target for the shares to $64.50 from $71.50. The analyst reduced his estimates to reflect more concern about the company's net interest margin prospects and possibly forward growth. He sees "too many near-term challenges for a rise in the valuation or estimates."
04/18/19
COMP
04/18/19
DOWNGRADE
COMP
Neutral
Texas Capital downgraded to Neutral from Buy at Compass Point
03/27/19
03/27/19
DOWNGRADE
Target $59

Neutral
Texas Capital downgraded to Neutral on limited upside potential at Wedbush
As previously reported, Wedbush analyst Peter Winter downgraded Texas Capital to Neutral from Outperform and lowered his price target on the shares to $59 from $65. While the analyst recognizes the stock is cheap trading, given ongoing credit issues and an asset sensitive balance sheet against a more dovish Fed, he believes these two overhangs could limit upside potential.
IBM IBM
$143.07

-0.47 (-0.33%)

07/09/19
STFL
07/09/19
NO CHANGE
Target $169
STFL
Buy
Red Hat closing probably earlier than most expected, says Stifel
Stifel analyst David Grossman said IBM's (IBM) closing of its Red Hat (RHT) acquisition probably came earlier than most expected, adding that IBM will report standalone Q2 results next week, on July 17, and than will provide an update including Red Hat on a webcast scheduled for August 2. IBM is set up as a defensive holding with two potential catalysts, namely continued improvement in its core infrastructure services business and demonstrated success in leveraging Red Hat, said Grossman, who keeps a Buy rating and $169 price target on IBM shares.
06/21/19
WBLR
06/21/19
DOWNGRADE
WBLR
Market Perform
Red Hat downgraded to Market Perform from Outperform at William Blair
William Blair analyst Jason Ader downgraded Red Hat (RHT) to Market Perform from Outperform citing the nearing of the takeover by IBM (IBM).
06/21/19
NEED
06/21/19
NO CHANGE
NEED
Hold
Red Hat acquisition by IBM 'well on track', says Needham
Needham analyst Jack Andrews kept his Hold rating on Red Hat (RHT) after its Q1 earnings beat that was helped in part by the tax benefits from merger-related costs, saying the company's growth in its Infrastructure business has remained strong and its large-deal metrics were "solid". The analyst notes that while the company made no further updates on its pending IBM (IBM) acquisition, its recent approval by the DOJ and speculation of "unconditional" approval by E.U. regulators suggest that the completion of the deal remains "well on track".
06/06/19
DADA
06/06/19
NO CHANGE
Target $9
DADA
Buy
Cloudera price target lowered to $9 from $23 at DA Davidson
DA Davidson analyst Rishi Jaluria lowered his price target on Cloudera (CLDR) to $9 after its "disastrous" quarter with a reset of the company's recurring revenue expectations, resignation of its CEO, and weak bookings, as customers await the release of Cloudera Data Platform, or CDP. The analyst also points to Cloudera's higher churn, and increased competitiveness from Amazon's (AMZN) AWS, Microsoft's (MSFT) Azure, and Google's (GOOGL) GCP impacting the quarter. Jaluria cuts his FY21 EPS view to (19c) from 22c but maintains his Buy rating on Cloudera, citing his "glimmer of hope" that the company can reaccelerate growth with CDP or that either a private equity firm or IBM (IBM) would acquire it given the reduced 1.8-times enterprise value to expected 2020 revenue valuation.
AMRN Amarin
$21.06

-0.68 (-3.13%)

07/09/19
JEFF
07/09/19
NO CHANGE
JEFF
Buy
Amarin weakness may be due to hiring worries, Citizen's Petition, says Jefferies
Jefferies analyst Michael Yee noted that Amarin shares have been weak today and he said that investors he has spoke with have discussed the company's plans to double its salesforce near-term, which would increase operating expenses and the use of cash. Yee said he is also aware that there was a Citizen's Petition filed today by a group seeking to invalidate the company's '146 manufacturing patent, challenging the concept of producing pure EPA from crude fish oil. However, he said that a Citizen Petitions to invalidate a patent would seem challenging, as he thinks the more appropriate medium would be a formal court process or an IPR challenge. The petition "sounds noisy," added Yee, who has a Buy rating on Amarin shares.
07/09/19
AGIS
07/09/19
INITIATION
Target $3
AGIS
Buy
Aegis starts 'promising Omega-3 story' Acasti with Buy rating, $3 price target
As previously reported, Aegis analyst Nathan Weinstein initiated Acasti Pharma (ACST) with a Buy rating and $3 price target, telling investors that the company's Omega-3 therapeutic for the treatment of very high triglycerides, called CaPre, has demonstrated "interesting efficacy" in phase 2 study. Several companies have entered or could be close to entering the prescription Omega-3 space, including Amarin (AMRN), but Weinstein points to precedent cases of third and later entrants achieving market success in various therapeutic categories.
07/03/19
ROTH
07/03/19
NO CHANGE
Target $31
ROTH
Buy
Amarin 'just getting started' as Vascepa sales sets new high, says Roth Capital
Roth Capital analyst Yasmeen Rahimi notes that Amarin provided record revenue for the first half of 2019 for Vascepa, guided $380M-420M for 2019 and unveiled its plans to increase its U.S. sales team to about 800 in October 2019. The analyst believes the company's power move is just the beginning of transformation into a money maker, while noting that there is still no word on AdCom as PDUFA approaches. Rahimi reiterates a Buy rating and $31 price target on the shares.
07/03/19
HCWC
07/03/19
NO CHANGE
Target $51
HCWC
Buy
Amarin guidance highlights continued Vascepa traction, says H.C. Wainwright
Amarin's updated revenue guidance yesterday highlights the continued U.S. prescription traction of Vascepa, H.C. Wainwright analyst Andrew Fein tells investors in a research note. The analyst finds the guidance updates in line with his 100 physician survey, which suggests Amarin "remains in the early stages of Vascepa launch with significant upside ahead coinciding with growing physician awareness." Fein reiterates a Buy rating on the shares with a $51 price target.
ROKU Roku
$109.33

-2.575 (-2.30%)

06/05/19
06/05/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Roku (ROKU) upgraded to Buy from Neutral at Guggenheim with analyst Michael Morris saying he sees "strong secular tailwinds" for streaming video consumption and believes the company's Q1 results were representative of the core trajectory for its key metrics. 2. Cronos Group (CRON) double upgraded to Buy from Underperform at BofA/Merrill with analyst Christopher Carey saying he has improved confidence that Cronos is near announcing a launch in the U.S., following recent comments by management. 3. Medtronic (MDT) upgraded to Outperform from Market Perform at Wells Fargo with analyst Lawrence Biegelsen saying the company's late stage pipeline will accelerate its growth into fiscal 2021. 4. e.l.f. Beauty (ELF) upgraded to Equal Weight from Underweight at Morgan Stanley with analyst Dara Mohsenian saying he views valuation as more reasonable following the 53% drop in the stock over the last year. 5. FleetCor (FLT) and Wex (WEX) upgraded to Buy from Neutral at Goldman Sachs. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/01/19
RBCM
07/01/19
DOWNGRADE
Target $90
RBCM
Sector Perform
Roku downgraded to Sector Perform from Outperform at RBC Capital
RBC Capital analyst Mark Mahaney downgraded Roku to Sector Perform from Outperform with an unchanged price target to $90.
07/01/19
RBCM
07/01/19
DOWNGRADE
Target $90
RBCM
Sector Perform
Roku downgraded to Sector Perform on valuation at RBC Capital
RBC Capital analyst Mark Mahaney downgraded Roku to Sector Perform from Outperform with an unchanged price target of $90. The stock closed Monday up 79c to $91.37. The analyst cites valuation for the downgrade with the shares up 200% year-to-date. He sees a less compelling risk/reward at current share levels. Mahaney says he'd be constructive again on any major stock pullback in the stock.
07/02/19
07/02/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Roku (ROKU) downgraded to Sector Perform from Outperform at RBC Capital with analyst Mark Mahaney citing valuation. 2. Dave & Buster's (PLAY) downgraded to Hold from Buy at Jefferies with analyst Andy Barish saying his competitive overlap analysis reveals high exposure for the company to increasing competition while data checks suggest limited same-store-sales visibility. 3. Westlake Chemical (WLK) downgraded to Equal Weight from Overweight at Barclays with analyst Michael Leithead saying he believes the valuation is no longer compelling given the U.S. ethylene cycle. 4. Trade Desk (TTD) downgraded to Sector Perform from Outperform at RBC Capital with analyst Mark Mahaney citing valuation. 5. Stryker (SYK) downgraded to In Line from Outperform at Evercore ISI. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
NYMT New York Mortgage
$6.25

-0.01 (-0.16%)

09/28/18
KBWI
09/28/18
NO CHANGE
Target $5.5
KBWI
Market Perform
Keefe Bruyette recommends short-term underweight on New York Mortgage
Keefe Bruyette analyst Eric Hagen believes a short-term underweight position in New York Mortgage is an effective way to capture upside as a result of tight credit spreads. At 1.07 times of GAAP book value, the stock appears overvalued given the earnings risk if yields on core assets such as CMBS and distressed residential loans either remain tight or widen sharply, Hagen tells investors in a research note. He reiterates a Market Perform rating on the shares with a $5.50 price target.
03/26/19
NOMU
03/26/19
INITIATION
Target $6.5
NOMU
Buy
New York Mortgage initiated with a Buy at Nomura Instinet
Nomura Instinet analyst Matthew Howlett started New York Mortgage Trust with a Buy rating and $6.50 price target. The analyst says the company has "flown the under the radar for most of its post Financial Crisis existence," despite generating economic returns well above those of the mortgage real estate investment trust peer group. He expects the stock to outperform in 2019. The analyst also initiated coverage of the U.S. Mortgage REITs industry with a positive outlook. The environment for levered mortgage-based operating models is the best it's been since the Taper Tantrum, Howlett tells investors in a research note. He thinks the space is poised to attract interest from "yield-starved investors amid a low, range-bound interest rate environment and expected yield curve steepening."
08/06/18
LTCO
08/06/18
DOWNGRADE
LTCO
Neutral
New York Mortgage downgraded to Neutral from Buy at Ladenburg
Ladenburg Thalmann analyst Christopher Nolan downgraded New York Mortgage Trust to Neutral citing valuation following the company's core earnings miss in Q2. The analyst removed his prior $6.25 price target for the shares.
02/28/19
LEHM
02/28/19
DOWNGRADE
Target $5
LEHM
Underweight
New York Mortgage downgraded to Underweight from Equal Weight at Barclays
Barclays analyst Mark Devries downgraded New York Mortgage Trust to Underweight with a $5 price target.

TODAY'S FREE FLY STORIES

DB

Deutsche Bank

$6.98

-0.19 (-2.65%)

, COF

Capital One

$83.06

-2.68 (-3.13%)

17:57
08/23/19
08/23
17:57
08/23/19
17:57
Periodicals
Deutsche Bank, Capital One won't say if they have Trump's tax returns, NYP says »

Deutsche Bank (DB) and…

DB

Deutsche Bank

$6.98

-0.19 (-2.65%)

COF

Capital One

$83.06

-2.68 (-3.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

MXIM

Maxim Integrated

$52.14

-2.42 (-4.44%)

17:53
08/23/19
08/23
17:53
08/23/19
17:53
Hot Stocks
Maxim Integrated's Jain sells 12,683 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

GLD

SPDR Gold Shares

$144.15

2.77 (1.96%)

17:42
08/23/19
08/23
17:42
08/23/19
17:42
Hot Stocks
SPDR Gold Shares holdings rise to 859.83MT to 854.84MT »

This is the fourth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AUMN

Golden Minerals

$0.27

0.0159 (6.38%)

17:33
08/23/19
08/23
17:33
08/23/19
17:33
Hot Stocks
Golden Minerals receives noncompliance notice from NYSE »

Golden Minerals announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DMPI

DelMar Pharmaceuticals

$0.77

0.0047 (0.61%)

17:25
08/23/19
08/23
17:25
08/23/19
17:25
Hot Stocks
Intracoastal Capital reports 9.99% passive stake in DelMar Pharmaceuticals »

Intracoastal Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RTN

Raytheon

$180.58

-6.44 (-3.44%)

17:22
08/23/19
08/23
17:22
08/23/19
17:22
Hot Stocks
Raytheon awarded $534M Army contract »

Raytheon was awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UHAL

Amerco

$339.43

-2.97 (-0.87%)

17:21
08/23/19
08/23
17:21
08/23/19
17:21
Hot Stocks
Amerco announces special cash dividend of 50c per share »

The dividend will be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTLA

Intellia Therapeutics

$15.77

-1.08 (-6.41%)

17:20
08/23/19
08/23
17:20
08/23/19
17:20
Syndicate
Breaking Syndicate news story on Intellia Therapeutics »

Intellia Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GD

General Dynamics

$183.42

-4.19 (-2.23%)

17:19
08/23/19
08/23
17:19
08/23/19
17:19
Hot Stocks
General Dynamics awarded $1.08B Navy contract modification »

General Dynamics has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVLN

Novelion Therapeutics

$0.66

-0.0523 (-7.37%)

17:17
08/23/19
08/23
17:17
08/23/19
17:17
Hot Stocks
Stonepine Capital reports 6.1% passive stake in Novelion Therapeutics »

Stonepine Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMT

Lockheed Martin

$376.85

-8.91 (-2.31%)

17:14
08/23/19
08/23
17:14
08/23/19
17:14
Hot Stocks
Lockheed Martin awarded $2.43B Navy contract modification »

Lockheed Martin has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ONCS

OncoSec

$1.84

-0.03 (-1.60%)

17:14
08/23/19
08/23
17:14
08/23/19
17:14
Syndicate
Breaking Syndicate news story on OncoSec »

OncoSec files $50M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TNXP

Tonix Pharmaceuticals

$0.42

-0.0249 (-5.60%)

17:09
08/23/19
08/23
17:09
08/23/19
17:09
Syndicate
Breaking Syndicate news story on Tonix Pharmaceuticals »

Tonix Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$284.86

-7.5 (-2.57%)

17:08
08/23/19
08/23
17:08
08/23/19
17:08
General News
Trump to raises tariff rates on Chinese goods, CNBC says »

U.S. President Donald…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$284.86

-7.5 (-2.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATIS

Attis Industries

$1.03

-0.08 (-7.21%)

17:06
08/23/19
08/23
17:06
08/23/19
17:06
Hot Stocks
Attis Industries provides update on status of Nasdaq listing »

Attis Industries…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVEO

Civeo

$1.32

-0.07 (-5.04%)

17:04
08/23/19
08/23
17:04
08/23/19
17:04
Syndicate
Breaking Syndicate news story on Civeo »

Civeo files $300M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGO

Assured Guaranty

$42.56

-1.09 (-2.50%)

16:58
08/23/19
08/23
16:58
08/23/19
16:58
Hot Stocks
Assured Guaranty CEO sells 30,300 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RMED

Ra Medical Systems

$1.87

-0.055 (-2.86%)

16:50
08/23/19
08/23
16:50
08/23/19
16:50
Hot Stocks
Ra Medical Systems discloses NYSE notice related to 10-Q filing delay »

Ra Medical Systems…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBA

Pembina Pipeline

$35.73

-0.81 (-2.22%)

16:47
08/23/19
08/23
16:47
08/23/19
16:47
Syndicate
Breaking Syndicate news story on Pembina Pipeline »

Pembina Pipeline files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

APEN

Apollo Endosurgery

$3.50

(0.00%)

16:44
08/23/19
08/23
16:44
08/23/19
16:44
Syndicate
Breaking Syndicate news story on Apollo Endosurgery »

Apollo Endosurgery files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:40
08/23/19
08/23
16:40
08/23/19
16:40
General news
Fed's Clarida said the global economy has worsened »

Fed's Clarida said…

LQDA

Liquidia Technologies

$5.23

-0.38 (-6.77%)

16:35
08/23/19
08/23
16:35
08/23/19
16:35
Syndicate
Breaking Syndicate news story on Liquidia Technologies »

Liquidia Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

V

Visa

$175.24

-4.91 (-2.73%)

16:32
08/23/19
08/23
16:32
08/23/19
16:32
Hot Stocks
Visa CFO Prabhu sells over 25,000 class A common shares »

Visa vice chairman and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

  • 27

    Oct

QCOM

Qualcomm

$73.57

-3.55 (-4.60%)

16:31
08/23/19
08/23
16:31
08/23/19
16:31
Hot Stocks
Qualcomm CFO Dave Wise to retire, Akash Palkhiwala named interim CFO »

Qualcomm announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

  • 06

    Nov

ANFI

Amira Nature Foods

$0.58

-0.0144 (-2.44%)

16:30
08/23/19
08/23
16:30
08/23/19
16:30
Hot Stocks
Amira Nature Foods receives NYSE notice over late Form 20-F filing »

Amira Nature Food…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.